2 results
Approved WMORecruiting
To identify if, how and when VR is of added value in current treatment methods for people with SAD and MBID.
Approved WMORecruitment started
This PIONEER IV trial aims to demonstrate a non-inferiority of QFR-guidance PCI to usual care PCIwith respect to Patient oriented Composite Endpoint (PoCE) at 1 year with the unrestricted use ofHT Supreme-SES in an all-comers…